Immunosuppression in Patients with Metastatic Squamous Cell Carcinoma from the Skin
- 1 March 1990
- journal article
- Published by Wiley in The Journal of Dermatologic Surgery and Oncology
- Vol. 16 (3) , 271-274
- https://doi.org/10.1111/j.1524-4725.1990.tb03963.x
Abstract
Sixteen of 70 patients with metastatic squamous cell carcinoma (SCC) from the skin had evidence of clinical immunosuppression. In addition to patients with lymphoproliferative disorders or renal failure, those with cicatricial pemphigoid and those undergoing chronic oral corticosteroid therapy were identified as being at high risk. Host immune surveillance appears to play a major role in determining the metastatic potential of cutaneous SCC.Keywords
This publication has 15 references indexed in Scilit:
- Metastases from squamous cell carcinoma of the skin and lipJournal of the American Academy of Dermatology, 1989
- Cutaneous malignancies and metastatic squamous cell carcinoma following topical therapies for mycosis fungoidesJournal of the American Academy of Dermatology, 1986
- Cicatricial PemphigoidInternational Journal of Dermatology, 1986
- Metastatic squamous cell carcinoma of the skin occurring in a lymphomatous lymph nodeJournal of the American Academy of Dermatology, 1985
- Occurrence of Cicatricial Pemphigoid and Leiomyosarcoma in a Psoriatic PatientDermatology, 1985
- Aggressive Biologic Behavior of Basal‐ and Squamous‐Cell Cancers in Patients with Chronic Lymphocytic Leukemia or Chronic Lymphocytic LymphomaThe Journal of Dermatologic Surgery and Oncology, 1979
- INCREASED INCIDENCE OF MALIGNANCY DURING CHRONIC RENAL FAILUREThe Lancet, 1975
- SKIN CANCER AND IMMUNOSUPPRESSIONThe Lancet, 1971
- CARCINOMA IN BENIGN MUCOUS MEMBRANE PEMPHIGOID (OCULAR PEMPHIGUS).British Journal of Dermatology, 1962